The growing dependence on plastics is driving a sharp increase in environmental pollution, posing serious risks to human health. This issue necessitates immediate attention and proactive measures to mitigate its impact on both individuals and the broader ecosystem. From this viewpoint, biocompatible and biodegradable polymers, both synthetic and natural, have emerged as vital materials for applications in biomedicine, packaging, and environmental sustainability. The main advantages of biodegradable polymer materials lie in conserving fossil fuel resources, utilizing inedible biomass, and enabling environmentally friendly production processes. In this context, this review thoroughly discusses the categorization of biocompatible and biodegradable polymers into natural and synthetic types, detailing their structural characteristics, mechanisms of biodegradation, and compatibility matrices appropriate for biomedical, environmental, and industrial uses. It also addresses recent advancements in polymer synthesis technology, highlighting significant progress in polymer functionalization, responsiveness to stimuli, and environmentally friendly biobased synthesis methods. Additionally, it identifies challenges such as mechanical constraints, control over degradation, and expense, while also discussing future opportunities in the field of polymer science.
19 March 2025 in European Journal of Medicinal Chemistry
Cancer drug delivery remains a critical challenge with systemic toxicity, poor drug bioavailability, and a lack of effective targeting. Overcoming these barriers is essential for improving treatment efficacy and patient outcomes. This review discusses current drug delivery techniques that reshape cancer therapy by offering precise, controlled-release tailored to tumor-specific features. Innovations in nanotechnology, immunotherapy, and gene therapy enable interventions at molecular and cellular levels. Radiomics and pathomics integrate high-dimensional data to optimize diagnostics and treatment planning. Combination therapy addresses the complexities of tumor heterogeneity by synergizing multiple agents within a single therapeutic framework, while peptide-drug conjugates enhance specificity and potency. Hydrogel-based systems and microneedle arrays offer localized, sustained release, significantly improving therapeutic outcomes. However, clinical translation of these advancements faces significant barriers such as drug resistance, off-target effects, scalability, cost, and ethical concerns. Moreover, regulatory complexities and the economic feasibility of these therapies highlight the need for innovative frameworks to make them accessible globally. Therefore, there is a need for innovation in gene and cell therapy, next-generation drug delivery platforms, and personalized medicine. This review focuses on recent advancements in drug delivery techniques over the past decade, evaluating their limitations and exploring potential future directions for transforming cancer treatment.
30 August 2021 in ACS Applied Materials & Interfaces
The increasing occurrence of infectious diseases caused by antimicrobial resistance organisms urged the necessity to develop more potent, selective, and safe antimicrobial agents. The unique magnetic and tunable properties of iron oxide nanoparticles (IONPs) make them a promising candidate for different theragnostic applications, including antimicrobial agents. Though IONPs act as a nonspecific antimicrobial agent, their antimicrobial activities are directly or indirectly linked with their synthesis methods, synthesizing precursors, size, shapes, concentration, and surface modifications. Alteration of these parameters could accelerate or decelerate the production of reactive oxygen species (ROS). An increase in ROS role production disrupts bacterial cell walls, cell membranes, alters major biomolecules (e.g., lipids, proteins, nucleic acids), and affects metabolic processes (e.g., Krebs cycle, fatty acid synthesis, ATP synthesis, glycolysis, and mitophagy). In this review, we will investigate the antibacterial activity of bare and surface-modified IONPs and the influence of physiochemical parameters on their antibacterial activity. Additionally, we will report the potential mechanism of IONPs' action in driving this antimicrobial activity.